ProCAncer-I at the RSNA 2022 in Chicago

Published on: December 1, 2022
Categories: News

Our Scientific Manager, Dr Nickolas Papanikolaou was at the 108th Scientific Assembly and Annual meeting (Chicago 27-30/11/2022).

The panel discussion included Dr Mona Flores, Global Head of Medical AI at NVIDIA, and Dr Nikos Papanikolaou, Computational Clinical Imaging Group Lead at the Champalimaud Foundation & Machine Learning Imaging Lead at the Royal Marsden Hospital, London. It was chaired by Dr Rowland Illing, Director & Chief Medical Officer, International Public Sector Health at AWS & Hon Assoc Prof at UCL, London. The panel entitled “Radiology AI Innovation: Academics vs Industry” described how researchers and radiologists can best leverage tech industry partners to accelerate their research, providing real-world examples of how this has taken place internationally. They described to a large audience of stakeholders the next generation of imaging AI capabilities that will be coming to market, and how the audience will be able to leverage these in the future.

Photo by Razvan Ionasec                   

 

ProCAncer-I: Session on RSNA 2022 by Quibim

Mark Wittenberg also presented a session at the RSNA 2022 in Chicago called “Advancements in Prostate MRI: Quibim” in which he communicated about ProCΑncer-I project

 

 

 

 

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!